These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28573249)

  • 1. HERBAL PRODUCT USE BY THE CANCER PATIENTS IN BOTH THE PRE AND POST SURGERY PERIODS AND DURING CHEMOTHERAPY.
    Koçaşlı S; Demircan Z
    Afr J Tradit Complement Altern Med; 2017; 14(2):325-333. PubMed ID: 28573249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals.
    Ben-Arye E; Samuels N; Goldstein LH; Mutafoglu K; Omran S; Schiff E; Charalambous H; Dweikat T; Ghrayeb I; Bar-Sela G; Turker I; Hassan A; Hassan E; Saad B; Nimri O; Kebudi R; Silbermann M
    Cancer; 2016 Feb; 122(4):598-610. PubMed ID: 26599199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and exploration of herb-drug combinations used by cancer patients.
    Engdal S; Klepp O; Nilsen OG
    Integr Cancer Ther; 2009 Mar; 8(1):29-36. PubMed ID: 19174505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potential risks, adverse effects and drug interactions associated with herbal medicine in dental patients].
    Zlotogorski Hurvitz A; Littner M
    Refuat Hapeh Vehashinayim (1993); 2004 Apr; 21(2):25-41, 97. PubMed ID: 15503544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey.
    Bush TM; Rayburn KS; Holloway SW; Sanchez-Yamamoto DS; Allen BL; Lam T; So BK; Tran de H; Greyber ER; Kantor S; Roth LW
    Altern Ther Health Med; 2007; 13(2):30-5. PubMed ID: 17405676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of chemotherapy-herb interactions in adult cancer patients.
    McCune JS; Hatfield AJ; Blackburn AA; Leith PO; Livingston RB; Ellis GK
    Support Care Cancer; 2004 Jun; 12(6):454-62. PubMed ID: 14991387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer agents and phytotherapy: Interactions that are often unrecognized.
    Laurent V; Saillard J; Thierry M; Lepelletier A; Fronteau C; Huon JF
    J Oncol Pharm Pract; 2021 Mar; 27(2):322-328. PubMed ID: 32356688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herbal product use in a sample of Turkish patients undergoing haemodialysis.
    Kara B
    J Clin Nurs; 2009 Aug; 18(15):2197-205. PubMed ID: 19207805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herbal medicine: a survey of use in Nigerian presurgical patients booked for ambulatory anaesthesia.
    Onyeka TC; Ezike HA; Nwoke OM; Onyia EA; Onuorah EC; Anya SU; Nnacheta TE
    BMC Complement Altern Med; 2012 Aug; 12():130. PubMed ID: 22906201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacovigilance of herb-drug interactions among preoperative patients.
    Gallo E; Pugi A; Lucenteforte E; Maggini V; Gori L; Mugelli A; Firenzuoli F; Vannacci A
    Altern Ther Health Med; 2014; 20(2):13-7. PubMed ID: 24657955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and predictors of using herbal medicines among Iranian cancer patients.
    Bazrafshani MS; Khandani BK; Pardakhty A; Tajadini H; Pour Afshar RM; Moazed V; Nemati A; Nasiri N; Sharifi H
    Complement Ther Clin Pract; 2019 May; 35():368-373. PubMed ID: 31003684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ethnomedicinal survey on phytotherapy with professionals and patients from Basic Care Units in the Brazilian Unified Health System.
    Oliveira SG; de Moura FR; Demarco FF; Nascente Pda S; Pino FA; Lund RG
    J Ethnopharmacol; 2012 Mar; 140(2):428-37. PubMed ID: 22338646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary and alternative medicine usage in cancer patients in southeast of Turkey.
    Kucukoner M; Bilge Z; Isıkdogan A; Kaplan MA; Inal A; Urakci Z
    Afr J Tradit Complement Altern Med; 2012; 10(1):21-5. PubMed ID: 24082321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway.
    Engdal S; Steinsbekk A; Klepp O; Nilsen OG
    Support Care Cancer; 2008 Jul; 16(7):763-9. PubMed ID: 18196289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential drug-herb interaction with antiplatelet/anticoagulant drugs.
    Saw JT; Bahari MB; Ang HH; Lim YH
    Complement Ther Clin Pract; 2006 Nov; 12(4):236-41. PubMed ID: 17030294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of use of herbal medicines among ambulatory hypertensive patients attending a secondary health care facility in Nigeria.
    Olisa NS; Oyelola FT
    Int J Pharm Pract; 2009 Apr; 17(2):101-5. PubMed ID: 20214258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements.
    Wolf CPJG; Rachow T; Ernst T; Hochhaus A; Zomorodbakhsch B; Foller S; Rengsberger M; Hartmann M; Hübner J
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):461-473. PubMed ID: 33864520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Herbal medicines--evidence and drug interactions in clinical practice].
    Kistorp TK; Laursen SB
    Ugeskr Laeger; 2002 Sep; 164(36):4161-5. PubMed ID: 12362826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential risks associated with the use of herbal anti-obesity products.
    Chan TY
    Drug Saf; 2009; 32(6):453-6. PubMed ID: 19459713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herbal medications in the treatment of benign prostatic hyperplasia (BPH).
    Fagelman E; Lowe FC
    Urol Clin North Am; 2002 Feb; 29(1):23-9, vii. PubMed ID: 12109350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.